Home
Account
Research Tools & Data
Educate
Contribute
News
ETFs
Sectors
About
Subscribe
Login
Manage Account
Quote and Research
Stock Charts
Earnings Calendar
Technical Scans
Economic Calendar
Chart School
Tutorials
Learning Center
Submit Article
Join Blog Network
Chat Rooms
Rate Broker
Rate Software
About Us
Contact Us
Advertise With Us
Terms and Conditions
Enter Symbol
Overview
Community Research
Stock Sentiment
Whisper Estimates
Enter Estimates
Company Profile
Technical Charts
Competitors
Analyst Ratings
Analyst Estimates
Sales Estimates
Related News
Blog Articles
Press Releases
Message Board
Option Chain
Financial Ratios
Technicals
SEC Filings
SANOFI-AVE(NYSE:SNY)
Sanofi-Synthlabo is a leading global pharmaceutical company.
# Employees:
98213
Address:
174 avenue de France,Paris,,FRA
Phone:
335 377 4076
Fax:
335 377 4174
Website:
www.sanofi-synthelabo.com
Email:
Sector:
Medical
Industry:
MED PRODUCTS
Executive Officers
Jean-Fran??ois Dehecq
(Chmn.; C.E.O.)
Marie H??l??ne Laimay
(Sr. V.P.; C.F.O.)
G??rard Le Fur
(Sr. V.P.; Exec. V.P.)
Christian Lajoux
(Sr. V.P.)
Hanspeter Spek
(Exec. V.P.,)
Dividend
Ex-Dividend Date:
1/1/1990
Annual Dividend:
$1.12
Current Dividend Yield:
$2.97
Dividend Paid (3 months):
$0.00
Indicated Dividend:
$0.25
Earnings
Last Earnings Date:
9/30/2009
Next Earnings Date(Expected):
2/10/2010
Mean EPS (Next Qtr):
$1.09
Mean EPS (Year):
$4.74
Mean Estimate(Long Term):
$3.17
P/E Ratio(Based on EPS estimate):
7.950
Number of Estimates:
6
Shares Performance
Period
SNY
Compare to S&P
YTD
17.13 %
-3.06 %
4 Weeks
-3.90 %
-4.94 %
12 Weeks
9.09 %
2.85 %
Shares Information
Analyst Coverage:
Y
Avg Volume:
1513111
Shares Outstanding:
2631M
Market Cap:
$99.11B
52 Week High:
$40.15
52 Week Low:
$25.02
P/E Ratio:
8.330
PEG Ratio:
2.510
Split:
On 1/1/1990 SNY split by factor of 0.170
Earnings Performance
EPS Growth in Last Quarter:
1.61 %
EPS Growth in Last Year:
17.76 %
Sales Growth in Last Quarter:
3.21 %
Sales Growth in Last Quarter:
7.84 %
Financials
Qtr Book Value:
$1.63
Cash Flow/Share:
$5.16
Change in Payout Ratio:
-0.010
Price/Sales:
2.450
Fundamental data is provided by
Zacks Investment Research
, market data is provided by
AlphaTrade.
, and Commentary and Press Releases provided by
Quotemedia